Subscribe to
this category


A total of 7 posts are filed under Pricing
ICER Issues Modified Framework for Assessing Value of Treatments for Ultra-Rare Diseases
Rare Daily Staff The Institute for Clinical and Economic Review, an independent non-profit research institute that analyzes the evidence on… Continue Reading
Paying for Value
The drug industry long justified the pricing of its products on the basis of the high cost of R&D and the need for successes to offset the… Continue Reading
Canadian Drug Watchdog Orders Alexion to Lower Price of Soliris, Refund Overcharges
Rare Daily Staff A Patented Medicine Prices Review Board Hearing Panel found Alexion Pharmaceuticals’ rare disease drug Soliris pricing… Continue Reading
New Therapies Pushing Orphan Drug Prices into Payers’ Crosshairs
Daniel S. Levine Rare disease therapies have been largely immune to the pricing battles over drugs, but controversy over the costs of new… Continue Reading